Bioxyne
Bioxyne Limited is an Australian-headquartered international consumer health and pharmaceutical company, incorporated in 2000, focusing on clinically effective health and wellness products, psychotropic and investigational medicines. The company operates in Australia, Europe, Japan, the United States, and the United Kingdom, offering a range of products including medicinal cannabis, psilocybin, MDMA, and health supplements. Bioxyne's wholly owned subsidiary, Breathe Life Sciences, is a licensed manufacturer, sponsor, importer, and exporter of controlled substances in Australia, with operations extending to the United Kingdom, Japan, and Europe. The company is listed on the Australian Securities Exchange under the ticker BXN.
- Biotech
- Healthtech
- Medtech
Investors
Investor